Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 3/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.65 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.65 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.65 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.65 |
| ▸ | DPP4 | P27487 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.65 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.65 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.65 |
| ▸ | GAPDH | P04406 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | STAT6 | P42226 | 1/20 | 0.65 |
| ▸ | PI4KA | P42356 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.65 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.65 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.65 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.65 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5448172 | 0.94 | ADORA1 (0.70) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL8820093 | 0.91 | ADORA1 (0.66) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL1237877 | 0.89 | ADORA3 (0.50) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL13268716 | 0.87 | ADK (0.64) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL24146591 | 0.87 | P2RY1 (0.63) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL24145122 | 0.85 | ADORA1 (0.61) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL27875834 | 0.85 | P2RY1 (0.75) | ADORA1SMN1; SMN2P2RY1P2RY2SRC | |
| SCHEMBL6901066 | 0.85 | DPP4 (0.69) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL6899705 | 0.85 | DPP4 (0.69) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B | |
| SCHEMBL6901068 | 0.85 | DPP4 (0.69) | ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120296087-A1 | MORPHOLINO-BASED ANTISENSE AGENT | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2012-11-22 | — | — | US | claimed |
| WO-2011018798-A2 | MORPHOLINO-BASED ANTISENSE AGENT | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2011-02-17 | — | — | WO | claimed |
| CN-120058705-A | Synthesis method of pharmaceutical intermediate PMO-G (N2-iBu) | 苏州诺维康生物科技有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-106795186-B | Process for preparing morpholino oligonucleotides | 味之素株式会社 | 2021-03-02 | — | — | CN | disclosed |
| CN-105228999-B | Process for preparing morpholino oligonucleotides | 味之素株式会社 | 2021-03-02 | — | — | CN | disclosed |
| US-9914745-B2 | Morpholino-based antisense agent | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2018-03-13 | — | — | US | disclosed |
| CN-106795186-A | The preparation method of morpholino oligonucleotide | 味之素株式会社 | 2017-05-31 | — | — | CN | disclosed |
| CN-105228999-A | The preparation method of morpholino oligonucleotide | AJINOMOTO KK | 2016-01-06 | — | — | CN | disclosed |
| US-20120296087-A1 | MORPHOLINO-BASED ANTISENSE AGENT | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2012-11-22 | — | — | US | disclosed |
| WO-2011018798-A2 | MORPHOLINO-BASED ANTISENSE AGENT | INDIAN ASSOCIATION FOR THE CULTIVATION OF SCIENCE (IN) | 2011-02-17 | — | — | WO | disclosed |
| WO-1997033590-A1 | A METHOD OF TREATING DISORDERS RELATED TO CYTOKINES IN MAMMALS | NOVO NORDISK A/S (DK) | 1997-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120296087-A1 | MORPHOLINO-BASED ANTISENSE AGENT | MYOF, OSBP2, SLCO2B1 | ADORA1 424/4885SMN1; SMN2 874/4885ADORA3 599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.